Prognostic Value of Vasodilator Stress Cardiac Magnetic Resonance Imaging: A Multicenter Study With 48 000 Patient-Years of Follow-up
暂无分享,去创建一个
R. Kim | R. Judd | R. Bonow | D. Shah | J. Weinsaft | M. Parker | Han W. Kim | A. Farzaneh-Far | I. Klem | C. Shenoy | Jiwon Kim | V. Polsani | Elizabeth R Jenista | Dany Debs | J. Heitner | J. Ho | A. Hughes | Preston Cargile | Andrew Hughes
[1] W. Rottbauer,et al. Comparing Cardiac Magnetic Resonance-Guided Versus Angiography-Guided Treatment of Patients With Stable Coronary Artery Disease: Results From a Prospective Randomized Controlled Trial. , 2018, JACC. Cardiovascular imaging.
[2] Amedeo Chiribiri,et al. Prognostic Value of Quantitative Stress Perfusion Cardiac Magnetic Resonance , 2017, JACC. Cardiovascular imaging.
[3] R. Califf,et al. Real-World Evidence - What Is It and What Can It Tell Us? , 2016, The New England journal of medicine.
[4] Jane Nixon,et al. A selection of recent, original research papers , 2016, Journal of Nuclear Cardiology.
[5] J. Greene,et al. Assessing the Gold Standard--Lessons from the History of RCTs. , 2016, The New England journal of medicine.
[6] D. Newby,et al. Diagnostic Strategies for the Evaluation of Chest Pain: Clinical Implications From SCOT-HEART and PROMISE. , 2016, Journal of the American College of Cardiology.
[7] A. Farzaneh-Far,et al. Downstream clinical consequences of stress cardiovascular magnetic resonance based on appropriate use criteria , 2015, Journal of Cardiovascular Magnetic Resonance.
[8] A. Jaffe,et al. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2015 .
[9] A. Jaffe,et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[10] R. Kim,et al. Stress cardiac MR imaging compared with stress echocardiography in the early evaluation of patients who present to the emergency department with intermediate-risk chest pain. , 2014, Radiology.
[11] A. Farzaneh-Far,et al. Assessment of global myocardial perfusion reserve using cardiovascular magnetic resonance of coronary sinus flow at 3 Tesla , 2014, Journal of Cardiovascular Magnetic Resonance.
[12] I. Tannock,et al. Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence , 2014, British Journal of Cancer.
[13] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[14] R. Kwong,et al. Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients , 2013, Journal of Cardiovascular Magnetic Resonance.
[15] Christopher M. Kramer,et al. Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. , 2013, Journal of the American College of Cardiology.
[16] A. Soricelli,et al. The Prognostic Value of Normal Stress Cardiac Magnetic Resonance in Patients With Known or Suspected Coronary Artery Disease: A Meta-analysis , 2013, Circulation. Cardiovascular imaging.
[17] J. Schwitter,et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. , 2013, European heart journal.
[18] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[19] S. Plein,et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial , 2012, The Lancet.
[20] Hester F. Lingsma,et al. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration , 2012, European journal of clinical investigation.
[21] Richard D. White,et al. Prognostic Value of Routine Cardiac Magnetic Resonance Assessment of Left Ventricular Ejection Fraction and Myocardial Damage: An International, Multicenter Study , 2011, Circulation. Cardiovascular imaging.
[22] R. Hachamovitch,et al. Incremental Prognostic Significance of Combined Cardiac Magnetic Resonance Imaging, Adenosine Stress Perfusion, Delayed Enhancement, and Left Ventricular Function Over Preimaging Information for the Prediction of Adverse Events , 2011, Circulation.
[23] Guido Germano,et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. , 2011, European heart journal.
[24] R. Kwong,et al. Measuring myocardial scar by CMR. , 2011, JACC. Cardiovascular imaging.
[25] M. Hamon,et al. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[26] Raymond J. Kim,et al. Utilidad diagnóstica de la resonancia magnética cardiovascular en pacientes con dolor torácico, enzimas cardiacas elevadas y ausencia de obstrucción arterial coronaria , 2009 .
[27] R. Kim,et al. The diagnostic utility of cardiovascular magnetic resonance in patients with chest pain, elevated cardiac enzymes and non-obstructed coronary arteries. , 2009, Revista espanola de cardiologia.
[28] Thomas H. Marwick,et al. Prediction of All-Cause Mortality From Global Longitudinal Speckle Strain: Comparison With Ejection Fraction and Wall Motion Scoring , 2009, Circulation. Cardiovascular imaging.
[29] F. Harrell,et al. Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.
[30] A. van Rossum,et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. , 2008, European heart journal.
[31] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[32] R. Carlos,et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. , 2007, Journal of the American College of Cardiology.
[33] Igor Klem,et al. mproved Detection of Coronary rtery Disease by Stress Perfusion ardiovascular Magnetic Resonance With he Use of Delayed Enhancement Infarction Imaging , 2006 .
[34] D. Berman,et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? , 2003, Journal of the American College of Cardiology.
[35] E J Topol,et al. Cause of death in clinical research: time for a reassessment? , 1999, Journal of the American College of Cardiology.
[36] D. Berman,et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. , 1998, Circulation.
[37] S. Connolly,et al. Standardized Reporting of ICD Patient Outcome: The Report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9–10, 1993 , 1993, Pacing and clinical electrophysiology : PACE.